Literature DB >> 2666141

Effect of zolpidem on sleep in insomniac patients.

J M Monti1.   

Abstract

The effect of zolpidem 10 mg p.o. on sleep in patients with persistent psychophysiological insomnia was assessed by polysomnographic recordings. An improvement in sleep with no rebound insomnia was observed during treatment for two weeks. Time awake after the onset of sleep was reduced after one week and increased after two weeks, whereas sleep latency remained reduced. Zolpidem markedly increased the duration of Stage 2 sleep without affecting either slow wave sleep or REM sleep. Subjective evaluation of improvement in sleep was well correlated with sleep laboratory findings. Zolpidem did not impair the immediate memory or psychomotor performance of patients on the morning after its administration. Side-effects during the period of drug administration included drowsiness, fatigue, headache, anxiety and irritability. They were mild or moderate and wore off soon after awakening.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666141     DOI: 10.1007/bf00558070

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  Short-term sleep laboratory evaluation of midazolam in chronic insomniacs. Preliminary results.

Authors:  J M Monti; P Alterwain; J Debellis; H Altier; T Pellejero; D Monti
Journal:  Arzneimittelforschung       Date:  1987-01

3.  Pharmacological and medical considerations in hypnotic use.

Authors:  T Roth; F Zorick; R Wittig; T Roehrs
Journal:  Sleep       Date:  1982       Impact factor: 5.849

4.  Sleep laboratory study of the effects of midazolam in insomniac patients.

Authors:  J M Monti; J Debellis; E Gratadoux; P Alterwain; H Altier; L D'Angelo
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  The utility of the REM latency test in psychiatric diagnosis: a study of 81 depressed outpatients.

Authors:  H S Akiskal; H Lemmi; B Yerevanian; D King; J Belluomini
Journal:  Psychiatry Res       Date:  1982-08       Impact factor: 3.222

6.  Sleep laboratory and clinical studies of the effects of triazolam, flunitrazepam and flurazepam in insomniac patients.

Authors:  J M Monti
Journal:  Methods Find Exp Clin Pharmacol       Date:  1981 Sep-Oct

7.  Hypnotic activity of an imidazo-pyridine (zolpidem).

Authors:  A N Nicholson; P A Pascoe
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

8.  Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.

Authors:  H Depoortere; B Zivkovic; K G Lloyd; D J Sanger; G Perrault; S Z Langer; G Bartholini
Journal:  J Pharmacol Exp Ther       Date:  1986-05       Impact factor: 4.030

9.  High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors.

Authors:  S Arbilla; J Allen; A Wick; S Z Langer
Journal:  Eur J Pharmacol       Date:  1986-11-04       Impact factor: 4.432

  9 in total
  18 in total

1.  Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.

Authors:  G Bensimon; J Foret; D Warot; L Lacomblez; J F Thiercelin; P Simon
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

2.  Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task.

Authors:  Karina A Zanin; Camilla L Patti; Leandro Sanday; Luciano Fernandes-Santos; Larissa C Oliveira; Dalva Poyares; Sergio Tufik; Roberto Frussa-Filho
Journal:  Psychopharmacology (Berl)       Date:  2012-06-23       Impact factor: 4.530

Review 3.  Prescribing short-acting hypnosedatives. Current recommendations from a safety perspective.

Authors:  D Wheatley
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

4.  Effect of zolpidem on sleep and sleep EEG spectra in healthy young men.

Authors:  D P Brunner; D J Dijk; M Münch; A A Borbély
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  Polysomnographic effects of hypnotic drugs. A review.

Authors:  L Parrino; M G Terzano
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

6.  Postoperative sleep disturbances after zolpidem treatment in fast-track hip and knee replacement.

Authors:  Lene Krenk; Poul Jennum; Henrik Kehlet
Journal:  J Clin Sleep Med       Date:  2014-03-15       Impact factor: 4.062

Review 7.  Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential.

Authors:  H D Langtry; P Benfield
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

8.  Effect of a single dose (10 mg) of zolpidem on visual and spectral analysis of sleep in young poor sleepers.

Authors:  O Benoit; G Bouard; C Payan; P Borderies; J Prado
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

9.  Relationship between zolpidem concentrations and sleep parameters in pediatric burn patients.

Authors:  Chris Stockmann; Michele M Gottschlich; Daniel Healy; Jane C Khoury; Theresa Mayes; Catherine M T Sherwin; Michael G Spigarelli; Richard J Kagan
Journal:  J Burn Care Res       Date:  2015 Jan-Feb       Impact factor: 1.845

Review 10.  Rebound insomnia and newer hypnotics.

Authors:  M Lader
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.